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Fibrous development of the extracellular matrix (ECM) of cardiac valves is necessary for proper heart
function. Pathological remodeling of valve ECM is observed in both pediatric and adult cardiac
disorders. It is well established that intracardiac hemodynamics play a signiﬁcant role in the
morphogenesis of cardiovascular tissues. However, the mechanisms that transduce mechanical forces
into morphogenetic processes are not well understood. Here, we report the development of a three-
dimensional, in vitro culture system that allows for culture of embryonic valve tissue under speciﬁc
pulsatile ﬂow conditions. This system was used to investigate the role that ﬂuid ﬂow plays in ﬁbrous
ECM expression during valve formation and to test the underlying cellular mechanisms that regulate
this mechanotransduction. When cultured under pulsatile ﬂow, developing valve tissues upregulated
ﬁbrous ECM expression at both the transcript and protein levels in comparison to no-ﬂow controls.
Flow-cultured valve tissues also underwent morphological development, as cushions elongated into
leaﬂet-like structures that were absent in no-ﬂow controls. Furthermore, rhoA, a member of the
cytoskeletal actin-regulating GTPase family of proteins, was upregulated and activated by ﬂow culture.
Inhibition of the downstream rhoA effector kinase, ROCK, blocked ﬂow-driven ﬁbrous ECM accumula-
tion and tissue stiffening, while the addition of lysophosphatidic acid (LPA), a rhoA activator, stimulated
ﬁbrous ECM deposition and tissue stiffening. These results support a prominent role for the rhoA
pathway in the mechanotransduction of hemodynamic forces during ﬁbrous remodeling of developing
valve tissue. Our results also point to a potential link between regulation of the actinomyosin
cytoskeleton and ﬁbrous ECM synthesis in cardiovascular tissues.
& 2012 Elsevier Inc. All rights reserved.Introduction
Malformation of the cardiac valves and septa are amongst the
most common and deadly of all human birth defects (Lloyd-Jones
et al., 2009). Experimental and clinical evidence have deﬁned a
prominent role for hemodynamic forces in the formation of these
cardiovascular tissues (Butcher et al., 2007; Hove et al., 2003).
Hemodynamic forces have also been implicated in pathological
remodeling of the extracellular matrix (ECM) that is associated
with cardiac malformations and adult disease (Sacks et al., 2009a;
Tao et al., 2012).ll rights reserved.
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, 80045.Cardiac valve development begins as paired of swellings or
cushions, which appear at the future site of the atrioventricular
(AV) valves and septum. Initially, these cushions are acellular and
ﬁlled with a mixture of glycosaminoglycans known as cardiac
jelly. Endocardial endothelial cells that cover the AV cushions
undergo an epithelial-to-mesenchymal transformation (EMT) and
migrate into the cushions and form the AV mesenchyme. In later
stages, cells from other embryonic tissues contribute to AV
mesenchyme including those derived from the epicardium and
the dorsal mesocardial protrusion (Briggs et al., 2012; Snarr et al.,
2008; Wessels et al., 2012). This complex AV mesenchyme gives
rise to the AV septum and the AV valve leaﬂets. As this mesench-
yme differentiates, ﬁbrous ECM proteins that are necessary for
normal cardiac function begin to be expressed.
Mature AV valves have been characterized as three stratiﬁed
ECM layers: the atrialis, the spongiosa, and the ﬁbrosa. Each layer
plays a speciﬁc role in withstanding the mechanical load of the
blood ﬂow (Hinton et al., 2006; Lincoln et al., 2006). The ﬁbrosa,
located on the ventricular side of the AV valve, consists primarily of
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strains, The atrialis, the portion of the AV valve that faces the atria, is
composed mainly of elastin and aids in valve closure. The spongiosa,
which lies between the atrialis and the ﬁbrosa, is composed of
glycosaminoglycans and acts to absorb intracardiac compressive
forces (Lincoln et al., 2006; Sacks et al., 2009a). Thus, mature AV
valve ECM is organized in accordance with its function throughout
the cardiac cycle, with each layer contributing its speciﬁc role.
However, it has been recently argued that valve ECM may in fact be
more complex than previously described (De Vlaming et al., 2012).
In earlier reports, we characterized the expression and localiza-
tion of ﬁbrous ECM proteins in valve tissue as it transitions from a
gelatinous cushion to a ﬁbrous valve leaﬂet (Norris et al., 2009; Tan
et al., 2011). These studies showed that col1 and tenascin C proteins
are expressed in the ECM during early AV septal development,
which divides the atria from ventricles, but also the left and right
sides of the heart. The TGFb-responsive protein, periostin, appears
to regulate col1 deposition, perhaps by inﬂuencing the differentia-
tion of cardiac mesenchyme towards a ﬁbroblastic phenotype
(Li et al., 2010; Norris et al., 2007). Thus, col1, periostin, and
tenascin C expression mark the ﬁbrous maturation of AV valvulo-
septal tissues. The generation of this AV ﬁbrous tissue is critical as it
creates both the physical and electrical barriers that are necessary
for normal heart function. However, mechanisms that regulate the
expression and localization of ﬁbrous ECM to speciﬁc regions
during cardiac development are not well understood.
Hemodynamic forces play a key role in development of the
valves and septa. In zebraﬁsh, impaired hemodynamics during early
embryonic development prevented valve formation altogether
(Hove et al., 2003). In numerous other embryological studies,
alteration of intracardiac ﬂow resulted in septal defects and valve
anomalies (Hogers et al., 1997, 1999; Hu and Clark, 1989; Lucitti
et al., 2005; Lucitti et al., 2006; Reckova et al., 2003; Stekelenburg-
de Vos et al., 2003). A common theme between these studies and
clinical characterization of pediatric and adult valve disease is that
abnormal hemodynamics are accompanied by pathological ECM
remodeling. While it is clear that hemodynamics and cardiovascular
ECM synthesis are linked, the mechanisms that connect the two are
difﬁcult to study in vivo, where numerous, unrelated variables can
confound experimental resolution.
To directly test the role of ﬂuid ﬂow on developing valve ECM
expression and to investigate the underlying cellular mechanisms of
mechanotransduction, we created a ﬂuid ﬂow bioreactor culture
system. This system builds upon our previous 3D in vitro model of
valve development in which valve tissues were cultured inside
spontaneously contracting ’cardiotubes’ (Goodwin et al., 2005;
Norris et al., 2009). Here, a positive displacement pump was used to
create ﬂow and stimulate ﬁbrous ECM synthesis and leaﬂet morpho-
genesis. We also report that rhoA, a member of the cytoskeletal actin-
regulating GTPase family of proteins, is upregulated and activated in
ﬂow-cultured valve tissue. Inhibition of rhoA coiled-coil containing
kinase (ROCK), a downstream effector of rhoA, reduced ﬁbrous ECM
synthesis, while stimulation of GTPase activity via lysophosphatidic
acid (LPA) enhanced ECM deposition. These results demonstrate that
ﬂuid-generated forces, such as shear stress, are sufﬁcient to stimulate
ﬁbrous ECM synthesis in developing valvuloseptal mesenchyme. Our
data also indicates that mechanical signals are transduced, in part, via
a rhoA pathway in developing cardiovascular tissues.Methods
Production of tubular scaffold cultures
Production of the 3-D tube scaffold composed of col1 has been
described in detail (Evans et al., 2003; Yost et al., 2004). Brieﬂy,a 25 mg/mL solution of bovine col1 is extruded with a device that
contains two counter-rotating cones. The liquid collagen is fed
between the two cones and forced through a circular annulus in
the presence of a NH3-air (50–50 v/v) chamber to polymerize the
collagen. The collagen tube scaffolds used in these studies have a
lumen diameter of 4 mm, an exterior diameter of 5 mm, and an
average pore size of 10 mm. Previous studies have demonstrated
that the collagen tube scaffold is well suited for the culture of
developing AV cushions (Goodwin et al., 2005; Norris et al., 2009).
AV cushion isolation
The AV cushions of Hamburger-Hamilton (HH) stage 25 chick
hearts were chosen for this study because they contain the
complex cardiac mesenchyme that develops into the ﬁbrous ECM
of the AV valves and septa during subsequent stages of cardiac
development. This is also the stage when the gelatinous cushions
begin to transition into ﬁbrous tissue as evidenced by the initial
deposition of col1 (Norris et al., 2009; Tan et al., 2011). Fertilized
white leghorn chicken eggs (Clemson University, SC) were incu-
bated in a humidity-controlled 37 1C incubator until they reached
HH stage 25 (approximately 4.5 days); (Hamburger and Hamilton,
1992). Embryos were removed from their shells and placed in the
Tyrodes buffer. AV explants were then microdissected and placed
inside the lumen of the tubular collagen scaffold using a micro-
pipette. Cushions were allowed to adhere to the lumen of the
collagen tube for 72 h prior to placement in the ﬂuid ﬂow
bioreactor system as described previously (Norris et al., 2009).
3D culture of AV explants in the ﬂuid ﬂow bioreactor system
A limitation of our study was that predicted in vivo levels of
shear stress could not be attained in our system. This limitation
was due in part to the scaffold diameter, as high levels of ﬂow
were required to match physiological levels of shear stress
through the 4 mm diameter tube. When such ﬂows were applied,
AV explants were ‘washed out’ of the tube scaffold. Thus, we
empirically determined the highest ﬂow rate that was permissive
for cushion bioreactor culture and used that as a starting point for
our experiments.
Hemodynamic forces ’ramp up’ during cardiac development
(Biechler et al., 2010; Butcher et al., 2007; Clark and Hu, 1982; Hu
and Clark, 1989), therefore, we sought to model this increase by
using a two-step ﬂow culturing protocol where ﬂow rate was
increased after three days of culture and explants were then
cultured for an additional four days. Although the shear stresses
applied to AV explants were signiﬁcantly smaller than reported
in vivo estimates, the relative increase (ramp) of the forces was
comparable to the 45% increase in shear stress seen between the
(HH) stage 24–27 chick (Clark and Hu, 1982). Further, the
investigation of cellular responses to these low levels has not
been investigated. For additional methods concerning the calibra-
tion and empirical testing of the ﬂow bioreactor system, please
refer to the Supplemental Data Section.
After the attachment phase (72 h of static culture), scaffolds
containing AV cushion explants were sutured onto the glass
nozzles of the bioreactor containing culture media: Dulbecco’s
Modiﬁed Eagle Medium (#50-013-PB, Corning cellgro) and 10%-
Fetal Bovine Serum (#F-0500-A, Atlas Biologicals) with Penicillin
Streptomycin (#P7794 and #S6501, Sigma–Aldrich), Amphoter-
icin B (#A9528, Sigma–Aldrich), and Minocycline (#M9511,
Sigma–Aldrich). A positive displacement pump (Ismatec, IDEX
Health & Science Group,) was connected to drive the culture
media through a pump cassette tube (0.64 mm inner diameter),
creating a closed system. During the dynamic culture period, the
initial (days 1–3) pump pulse frequency was 5.83102 Hz with
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average velocity were increased on day three to 0.29 Hz and
0.86 mm/s, respectively and cultured for four more days.
’No-ﬂow’ controls tubes were generated as described above and
sutured into bioreactors that were connected to a closed loop of
media without a pump. In this way, both the Flow and No Flow
groups were provided enough oxygen and nutrients during the
7 day culture period. The Y-27632 compound is a well-characterized
inhibitor of the rhoA effector kinase, p160ROCK, (Darenfed et al.,
2007) and was used to inhibit rhoA-speciﬁc signaling. Lysopho-
sphatidic acid is a bioactive phospholipid that binds to G-protein
coupled LPA receptors and activates rhoA (Rahaman et al., 2006). In
experiments using Y-27632 and LPA, cushion-scaffold co-cultures
were pre-soaked with Y-27632 (#688000, Calbiochem) at 5 mmol/L
or LPA (#L7260, Sigma–Aldrich) at 2 mmol/L, for 30 min before they
were placed in bioreactors. AV cushions were cultured as described
above in culture media that also contained Y-27632 at 5 mmol/L or
LPA at 2 mmol/L.
Shear stress calculations
To approximate the ﬂow-generated forces that occur in our
bioreactor system, a two-dimensional mathematical model was
used. The estimations were derived from computational model
simulations, which involve the use of a number of governing
equations and assumptions (described previously in Biechler
et al., 2010). Brieﬂy, we assumed that the culture media is an
incompressible, Newtonian ﬂuid passing through a 2D inﬁnite slit
representative of the idealized tubular scaffold containing a
mound-shaped AV explant. We also applied a no-slip condition
at the wall (no ﬂuid velocity) and inlet ﬂow conditions consistent
with the pump settings used during the in vitro experiments.
Stimulations were run using the Incompressible, Navier–Stokes,
Steady-State module of the COMSOL Multiphysics 3.4 (Burlington,
MA) software package.
Quantitative real time PCR
To obtain sufﬁcient quantities of RNA, 30 AV explants were
seeded into each tube culture, sutured into a bioreactor, and treated
with or without ﬂow as described above. Each experiment was
replicated three times. Total RNA was extracted using the RNeasy
Mini Kit (QIAGEN). RNA integrity and concentration were deter-
mined using an Agilent 2100 bioanalyzer and RNA 6000 nano
reagents (Agilent Technologies). 500 ng of total RNA was used for
each reverse transcription reaction using iScript cDNA synthesis kits
(Bio-Rad). Real-time PCR was performed on a Step One Plus real-
time PCR system using SYBR Green PCR MasterMix (Applied
Biosystems). Real-time PCR primers were designed in Beacon
Designer 6 software: Chicken Arbp (Forward: 50–CCT GTG ATG
TGA CTG TGC-30, Reverse: 50–ACT TTG TCT CCG GTC TTA ATC-30),
Chicken collagen I alpha I: (Forward: 50–TGG TGT TGA TAG CAG
CGA CT-30, Reverse: 50–GTG TCC TCG CAG ATC ACC TC-30); Periostin
(Forward: 50–GGA TGG TAT GAG AGG ATG TC-30, Reverse: 50–GCA
AAG AAA GTG AAT GAA CC-3’); Chicken tenascin C (Forward: 5’–
AGG ACA CAG CCT CTG CAA GT-3’, Reverse: 50–TAC TGC CCC TGA
GAG CTG AT-30); Chicken rhoA: (Forward: 50–CAG CAC CCT GCA
CTT GAG TA-30, Reverse: 50–GCA TCC TGT GAG TGC AGA AA-30). The
relative expression of target genes was calculated as previously
described by Pfafﬂ, which normalizes the differences between the
reaction kinetics of different primer sets (Pfafﬂ, 2001).
RhoA activation assays
RhoA activity was determined as a ratio of active/total rhoA
using colorimetric ELISA assays following the manufacturer’sprotocols. Brieﬂy, cultured AV explants were placed in lysis buffer
(#GL36, Cytoskeleton Inc.) with 0.001% by volume protease
inhibitor cocktail (#PIC02, Cytoskeleton Inc.). Samples were
sonicated and centrifuged to isolate tissue lysates. Protein con-
centrations were determined using Precision Red Advanced Pro-
tein Assay Reagent (Cytoskeleton Inc.). Lysate concentrations
were equilibrated to 1 mg/ml. The amount of rhoA protein (ng)
was determined using the Total RhoA ELISA Kit (#BK150, Cytos-
keleton Inc.). 50 mL of lysate and blank were pipetted, in triplicate,
into rho IgY-coated wells. RhoA levels were determined using the
horseradish peroxidase (HRP) conjugate secondary antibody sys-
tem that was provided. The amount of active rhoA (ng) was
determined using the Absorbance Based G-LISA RhoA Activation
Assay Biochem Kit (#BK124, Cytoskeleton Inc.) using the manu-
facturer’s protocol. In this assay, the plate wells are coated with a
rho-GTP binding protein that binds active (GTP-bound) rhoA. The
amount of active rhoA was detected with an HRP detection
system similar to the one described above. The percentage of
active rhoA was subsequently determined using the dividend of
active and total rhoA for each sample. (ﬂow: n¼8; no ﬂow: n¼3;
ﬂow w/ LPA: n¼11; ﬂow w/ Y-27632: n¼6).Western blotting analysis
Cultured AV explants were removed from the collagen tubes,
placed in lysis buffer with protease inhibitors (Pierce), and
disrupted using sonication. Protein supernatants were collected
via centrifugation. Protein concentrations of these lysates were
determined using a Bio-Rad Protein Assay Kit II (#500-0002, Bio-
Rad Laboratories) as described previously (Li et al., 2011).
Equal amounts of protein were loaded (5 mg) onto 4–20% SDS-
polyacrylamide gels (Pierce), and were resolved by electrophor-
esis and transferred to nitrocellulose membranes (for all groups,
n¼9 details?). Membranes were probed with primary antibodies
against tenascin C (#AB19013, Millipore), and GAPDH (#SC20357,
Santa Cruz) at concentrations of 1:2000. Goat anti-rabbit or goat
anti-mouse (Santa Cruz) secondaries were used at a concentration
of 1:2000 and detection was performed using enhanced chemi-
luminescence (Pierce).Confocal microscopy
Collagen tube scaffolds containing AV explants were removed
from the bioreactors and ﬁxed in 4% paraformaldehyde at room
temperature for 1 h. These tissues were embedded in 5% agarose
gels and cross-sectioned into 300 mm thick sections using a
vibratome (Oxford). Sections were then permeabilized with
0.25% triton X-100/PBS for 20 min at room temperature and
blocked with 2% BSA/PBS overnight at 4 1C. Sections were stained
for F-actin (phalloidin, # A12379, Invitrogen), tenascin C
(#AB19013, Millipore), col1 (#AB752P, Millipore) and periostin
(#AB1404.1, Abcam) using a concentration of 1:200 in BSA/PBS
overnight at 4 1C. No primary antibody controls were incubated in
PBS only overnight at 4 1C. The sections were then stained with
Alexa-conjugated secondary antibodies (Invitrogen) and DAPI
(#D21490, Invitrogen) overnight at concentrations of 1:200 and
1:5000, respectively, overnight at 4 1C. Sections were mounted
with elevated cover slips in DABCO (#D2522, Sigma–Aldrich).
Imaging was carried out using a Zeiss LSM 510 META confocal
laser scanning microscope (Carl Zeiss). Images were collected
using identical microscope settings for each channel. Gain was
adjusted for each channel to prevent excessive pixel saturation;
therefore, the reduced expression of tenascin C, col1, and periostin
is not indicative of a lack of protein expression.
Fig. 1. Tubular 3D AV cushion assay with ﬂuid ﬂow bioreactor system. (A) HH
stage 25 AV cushions were microdissected from chick hearts and placed inside a
tubular collagen scaffold. The cushions were allowed to adhere to the scaffold for
three days and then were sutured in bioreactors for an additional 7 day culture
period. (B) Bioreactors were ﬁlled with media, placed in an incubator, and (in the
case of ﬂow) were connected to a positive displacement pump. ’No-ﬂow’ controls
were produced in identical manner and sutured on bioreactors but not connected
to the pump.
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In AFM experiments (Veeco Multimode AFM), the AV explants
were adhered to a microscope slide and submerged in culture
media. A cantilever (0.12 N/m spring constant) with borosilicate
spherical tip (5 mm diameter) was used to indent tissue samples.
The cantilever was likely contacting cells (not ECM) with such as
small tip; however, the ECM proteins that surround the cell impact
the overall cell stiffness as well (Asparuhova et al., 2009). The tip
was indented approximately 1 mm into the tissue at a rate of 1 mm/s.
The cantilever deﬂection was measured and converted to force using
the tip’s associated Hook’s spring constant (Vandiver et al., 2005).
Data analysis was performed for each sample to determine tissue
stiffness. First, the Young’s modulus was calculated from the force–
distance curves using the Hertz Model (Darling et al., 2006; Hemmer
et al., 2008). The modulus, which characterizes the stiffness of a
linearly elastic material, should be lower for softer tissues. As with
most biological tissues, nanoindentation of the AV explants showed
a viscoelastic mechanical responses; however, the modulus values
calculated from this simple Hertzian analysis is a useful ﬁrst
approximation of tissue nanoindentation (Darling et al., 2006) and
can be used to broadly compare differences in tissue stiffness
between AV cushion samples. Qualitative analysis of representative
force–distance curves was also performed to investigate changes in
stiffness. For this analysis, a representative AFM curve was isolated
from each of the data sets and the curves were then compared. The
sharper the incline on the AFM curve is indicative of greater tissue
stiffness (e.g., the higher the slope the stiffer the tissue).
Statistical analysis
All data were expressed as Mean þ/ SEM. Statistical com-
parisons were performed using ANOVA or independent t-test by
SPSS 11.0 (SPSS Inc., Chicago, IL). P values o0.05 were considered
to be statistically signiﬁcant. For Western blot analyses, data
between groups were analyzed by a t-test with a Bonferroni
correction.Results
Flow regulates the expression and deposition of ﬁbrous ECM proteins
in AV cushions
AV cushions from HH stage 25 chick embryos were isolated,
seeded into the lumens of tubular collagen scaffolds, sutured onto
the bioreactors that were connected to a pulsatile pump, and
subjected to ﬂow (Fig. 1). No-ﬂow controls were sutured onto
bioreactors that were not connected to the pulsatile pump. In an
effort to mimic the effect of increasing cardiac shear stress that
occurs during in vivo development (Clark and Hu, 1982; Hu and
Clark, 1989), a two-step ﬂow protocol was used for ﬂow samples.
The velocity of the ﬁrst ﬂow phase (0.07 mm/s) was determined
empirically and corresponded to an estimated shear stress of
7.6104 Pa and a positive pressure of 4.3103 Pa. After three
days of ﬂow culture the velocity was increased to 0.86 mm/s, with
a calculated shear stress of 9.4103 Pa and a calculated positive
pressure of 0.053 Pa. This corresponded to a 92% increase in shear
stress over a four day period. While the magnitude of shear stress
used was not equivalent to predicted in vivo levels, this ramping
of shear stress (percent increase), was comparable. From HH stage
24–27, roughly a one day period, shear stress/ﬂow increases by
approximately 45% (Clark and Hu, 1982).
During the ﬁrst phase (days 1–3) of ﬂow culture, no differ-
ences were observed between ﬂow and no-ﬂow cultures. qRT-PCR
analysis found no signiﬁcant differences in the transcript levels ofcol1, tenascin C, and periostin (Fig. 2A). In contrast, AV cushions
cultured for 7 days in the two-step ﬂow protocol showed
signiﬁcant increases in col1, periostin, and tenascin-C transcripts
as compared to 7 day no-ﬂow controls (Fig. 2B). Col1 showed a
6.7 fold increase in transcript level in the 7 day ﬂow cultures over
no-ﬂow controls. Periostin and tenascin C showed a 2.8 and
2.4 fold increase, respectively, after 7 days of ﬂow culture as
compared to controls.
Differences in the distribution of cushion cells grown within
the tubular scaffold were also observed between the 7 day ﬂow
and no-ﬂow controls. In no-ﬂow controls, AV cushions formed a
loose network of cells that ﬁlled the lumen of the tube scaffold,
whereas 7 day ﬂow-cultured explants formed a compact, wedge-
shaped mass of cells (Fig. 3, Supplemental Movie 1 and 2). Leaﬂet-
like structures extended from these tissue wedges into the lumen
and curled away from the direction of ﬂow. Intense F-actin
staining was also observed in the 7 day ﬂow cultures, whereas
F-actin staining was sparse and diffuse in the no-ﬂow controls
(green staining, Fig. 3).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2012.11.023
The localization of tenascin C in the no-ﬂow controls was
sparse and evenly distributed throughout the cushion tissue (red
staining, Fig. 3B). In AV cushions cultured for 7 days in the two-
step ﬂow protocol, tenascin C was localized as extracellular
laminae inside the leaﬂet-like projections and at the cushion/
scaffold interface (arrows, Fig. 3E; Supplemental Movie 1 and 2).
RhoA is upregulated and activated in 7 day ﬂow cultures
Since ﬂow cultured AV cells showed evidence of extensive
F-actin staining, the cytoskeletal regulating GTPase, rhoA message
levels were investigated. qRT-PCR experiments showed a signiﬁ-
cant increase (35% increase) in rhoA transcript levels of 7 day,
ﬂow-cultured cushions as compared to no-ﬂow controls (Fig. 4A).
To determine if rhoA is activated in 7 day ﬂow-cultured AV
explants, the percentage of active, GTP-bound, rhoA to total rhoA
protein was determined. Day 7, ﬂow-cultured AV explants had
signiﬁcantly higher amounts of active rhoA exhibiting a 98%
increase in the percent of active rhoA when compared to no-ﬂow
controls (Fig. 4B).
Lysophosphatidic acid (LPA) activates rhoA through LPA
G-coupled membrane receptors, whereas the Y-27632 compound
inhibits the rhoA downstream effector kinase, ROCK (Darenfed
et al., 2007). These two effector molecules were used to probe the
Fig. 2. Affects of ﬂow on ﬁbrous ECM transcripts in 3D AV explant cultures. qRT-PCR analysis found no signiﬁcant differences in the transcript levels of ﬁbrous ECM
proteins during the initial stages (2 day) of the ﬂow protocol as compared to no-ﬂow controls (A). However, 7 day two-step ﬂow cultured AV cushions showed signiﬁcant
increases in Col1, periostin, and tenascin C mRNA expression increased 6.7, 2.8, and 2.4 fold, respectively, compared to no ﬂow groups. (B,* : Po0.01).
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ical signals in developing AV cushions. RhoA activity analysis
showed that 71% of rhoA was GTP-bound in 7 day ﬂow-cultured
cushions, whereas only 36% of rhoA is active in the no-ﬂow
controls. When Y-27632 was added to the ﬂow cultures the
percentage of active rhoA was 51%. The addition of LPA to the
two-step ﬂow protocol resulted in a 60% activation of rhoA
(Fig. 4B).
As our col1 and periostin antibodies are not suitable for
Western Blot analysis, the expression levels of tenascin C, an
ECM protein that is upregulated during valve maturation (Lincoln
et al., 2004), was determined. These studies found that tenascin C
was signiﬁcantly upregulated in 7 day ﬂow-cultured explants in
comparison to no-ﬂow controls (Fig. 5). The addition of LPA to no-
ﬂow cultures was found to signiﬁcantly upregulate tenascin C in
comparison to untreated no-ﬂow controls. Tenascin C protein
expression was signiﬁcantly downregulated in 7 day ﬂow-
cultured cushions in the presence of Y-27632 in comparison to
7 day ﬂow cultured cushions.
There were no signiﬁcant differences in tenascin C expression
among the ﬂow control (untreated media), the no ﬂow control
with LPA treated media, and the ﬂow group with LPA treatedmedia. Also, there were no signiﬁcant differences in tenascin C
expression among no ﬂow (untreated media), no ﬂow (Y-27632
treated), and ﬂow with Y-27632 treated groups.
The rhoA pathway regulates AV cushion ECM deposition.
To determine the roles of ﬂow and the rhoA pathway in the
expression and localization of ﬁbrous ECM proteins in developing
AV tissues, immunoﬂuorescent confocal analysis was carried out.
The same microscope settings were used for all images in Fig. 6 so
that relative ﬂuorescence could be gauged between sample
groups. Representative images of 7 day tube-cultured AV cush-
ions show the robust expression of col1 in ﬂow-cultured explants
in comparison to no-ﬂow controls (green staining, compare
Fig. 6A and D).
In the 7 day ﬂow-cultured AV explants, intense col1 staining
was observed in the mesenchyme near the explant/scaffold
interface and just under the luminal surface. Regions of intense
col1 staining were also found within the core of the cushions.
In no-ﬂow controls, col1 staining was sparse and diffusely
distributed throughout the AV mesenchyme. When 7 day ﬂow-
cultured explants were cultured in the presence of Y-27632, col1
Fig. 3. Flow affects protein expression and morphology of AV explants. Representative images of 7 day cultured AV explants stained for F-actin (green) and tenascin C (red)
are shown. These images are ﬂattened projections of confocal z-stacks of an entire 300 mm thick section. AV mesenchymal cells typically ﬁlled the lumen of the tubular
scaffold in 7 day ‘no-ﬂow’ cultures. Expression of F-actin was sparse and dispersed throughout the tissue. Expression of tenascin C was localized as extracellular ribbons of
staining that ran throughout the AV explant with no discernable orientation. AV explants grown for 7 days in the two-step ﬂow protocol formed a wedge-shaped cell mass
with intense F-actin staining. Tenascin C expression was localized as extracellular laminae that ran under the luminal surface of the AV explant and at the explant/scaffold
interface (arrows). For a 3D view of these samples please refer to the supplemental movies.
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exception of a layer of more intense staining on the luminal edge
of the cushion (Fig. 6E). This luminal staining was also observed in
no-ﬂow cushions cultured in the presence of LPA (Fig. 6C). Flow-
cultured explants cultured in the presence of LPA showed the
most intense col1 staining (Fig. 6F).
Similar results were found for confocal analyses of tenascin C
(Fig. 7). Analysis of periostin staining yielded somewhat different
results (Fig. 8). As in col1 and tenascin C, periostin protein
expression was more widely distributed throughout cushions
exposed to the 7 day two-step ﬂow protocol than no-ﬂow
controls (compare Fig. 8A and D). However, Y-27632 treatment
did not appear to affect periostin deposition (Fig. 8B and E).
Periostin expression was robust and widely distributed when
treated with LPA (Fig. 8C and F).
The rhoA pathway regulates AV cushion stiffening
Atomic force microscopy (AFM) is a technique that is capable
of resolving small differences in the material properties of sub-
stances and was used here to analyze the effect of ﬂow and rhoA
pathway modulators on the stiffness of AV cushion cells. Repre-
sentative force/distance curves that were used to calculate the
elastic moduli of cells on the surface of the AV explants are shown
in Fig. 9A. Day 7 ﬂow-cultured samples were found to have a
signiﬁcantly higher modulus than no-ﬂow controls (Fig. 9B). This
stiffening was inhibited when ﬂow cultures were grown in the
presence of Y-27632. Samples with the greatest modulus were
those exposed to ﬂow and the rho pathway activator, LPA.Discussion
Formation of valves and septa in the vertebrate heart is a
complex process involving numerous progenitor cell types. Thesecells go on to differentiate into the tissues that electrically insulate
the atria from the ventricles, form the ﬁbrous valve leaﬂets, and the
supporting annulus ﬁbrosus. The mesenchyme of the HH stage
25 cushion explants used in these studies contain progenitor cells
derived from endocardial, epicardial, and dorsal mesocardial sources
(Snarr et al., 2008; Wessels et al., 2012). This is also the stage at
which cushions initiate ﬁbrous ECM development, as marked by the
expression of col1 (Norris et al., 2009; Tan et al., 2011).
As valvuloseptal development continues, the AV cushions fuse,
physically separating pulmonary and systemic blood ﬂow in the
heart. Formation of this septum changes the geometry of the AV
canal and necessarily alters the distribution and magnitude of
intracardiac hemodynamic forces (Buskohl et al., 2012). However,
the intracardiac geometry during development is complex and
dynamic in both short (cyclic contraction) and long (morphogen-
esis) time dimensions. These dynamics make calculation of ﬂow-
generated forces on speciﬁc tissues difﬁcult (Biechler et al., 2010;
Buskohl et al., 2012; Butcher et al., 2007). Further, validation of
these calculations cannot be conﬁrmed in vivo. Thus, the use of an
in vitro system of development like the one presented in this
work allows for direct testing of the effect of speciﬁc ﬂow forces
on developing valve tissue and makes possible the experimental
validation of calculated forces.
The role that ﬂuid ﬂow plays in shaping the cardiovascular
system has long been the subject of investigation. In a non-
biological model of ﬂuid ﬂow in the cardiovascular system,
Rodbard was able to generate cushion and valve-like structures
by altering ﬂuid ﬂow in silicone gel-lined tubes (Rodbard, 1956).
Thus, ﬂuid ﬂow alone is capable of shaping malleable substances
into valve-like structures. Other investigations have provided
evidence that ﬂuid ﬂow is critical in shaping the tissues of the
developing cardiovascular system (Hall et al., 2004; Hove et al.,
2003; Reckova et al., 2003; Stekelenburg-de Vos et al., 2003;
Taber, 1998). In vivo experiments in which hemodynamic load
within the heart were altered showed signiﬁcant perturbations in
Fig. 4. Flow upregulates rhoA message levels and increases rhoA activation. (A) qRT-PCR showed a 1.34 fold increase in RhoA message levels when AV cushions were
cultured with ﬂow stimulation. (*: Po0.05). (B) Rho ELISA assays showed that 71% of the rhoA was phosphorylated in the 7 day two-step ﬂow protocol, whereas only 36%
of the rhoA was phosphorylated in no-ﬂow controls. When LPA or Y-27632 was added in conjunction with ﬂow, 60% and 51% of rhoA was phosphorylated, respectively.
H. Tan et al. / Developmental Biology 374 (2013) 345–356 351cardiac growth and development (Lucitti et al., 2005; Lucitti et al.,
2006; Schroeder et al., 2003; Sedmera et al., 2002a, 2002b). Valve
morphogenesis appears to be particularly sensitive to altered ﬂow
ﬁelds. Studies in both avian and ﬁsh models have shown that
valve development is severely affected when intracardiac hemo-
dynamics is disrupted (Hove et al., 2003; Sedmera et al., 1999).
In previous work, our group has used a tubular scaffold to
model the development of AV cushions into leaﬂet-like structures
(Goodwin et al., 2005). In these studies, valve morphogenesis was
dependent on co-culture with cardiac myocytes inside sponta-
neously contracting ’cardiotube’ cultures. In more recent studies,
the cardiotube system was used to investigate the role of
periostin in the differentiation and maturation of AV cushions
(Norris et al., 2009). Though these studies indicated that periostin
regulates cell lineage, ECM expression, and deposition, it did not
prevent leaﬂet formation, suggesting a role for ﬂow in this
process. To isolate the role of ﬂow, we developed a bioreactor
system to investigate if ﬂow-generated forces are capable of
driving valve morphogenesis and ﬁbrous ECM expression during
development.
As mentioned in the Methods section, a limitation of this study
was that predicted in vivo levels of shear stress could not be
attained in our current system, as AV explants were ‘washed out’
at the ﬂow rates required to match these stresses in a 4 mm
diameter tube. Thus, we empirically determined a ﬂow rate at
which ﬂow explants could be cultured, and used this ﬂow rate asa starting point for our studies. At this initial rate of ﬂow no
differences between ﬂow and no-ﬂow controls were observed
(Fig. 2A). As cardiac output increases during development
(Butcher et al., 2007; Clark and Hu, 1982; Hu and Clark, 1989),
we sought to model this escalating ﬂow by matching the
trajectory of increasing shear stress in our bioreactor system
and determine the effect on the ﬁbrous development. Another
limitation of the present study is we compare the two-step ramp
to no-ﬂow controls at the 7 day time point. Our system provides
the opportunity to study a wide range of ﬂow conditions. In the
future studies, we plan to investigate different pressure dynamics,
ﬂow rates, and regurgitant ﬂows, all of which may affect valve
development.
Though the shear stresses used in the 7 day two-step ﬂow
protocol were calculated to be well below in vivo estimates, AV
mesenchymal cells responded at the message, protein, and
morphological levels (Figs. 2, 3, and 5). Additionally, the spatio-
temporal expression patterns of ﬁbrous ECM proteins of 7 day
two-step ﬂow-cultured AV cushions were similar to in vivo
expression patterns at analogous stages of valve development
(HH 25–38); (Norris et al., 2009; Tan et al., 2011).
The 7 day two-step protocol also affected morphological
development of the AV cushions. In 7 day no-ﬂow explants, AV
cushion cells ﬁlled the lumen of the tube scaffold, whereas 7 day
ﬂow-cultured explants exhibited a wedge-shaped cell mass that
had a free edge that projected into the lumen of the tube scaffold
Fig. 5. Flow and rhoA regulate tenascin C expression in AV mesenchyme. (A) Western blotting showed that 7 day no-ﬂow AV cushions treated with LPA had higher
tenascin C expression than those treated with Y-27632 and the untreated control. With the 7 day two-step ﬂow protocol, Y-27632 treated AV cushions had signiﬁcantly
lower tenascin C expression than those treated with LPA and the ﬂow control. GAPDH was used as the loading control. (B) Comparisons among groups were done using a
t-test with a Bonferroni correction, and Po0.003 was considered statistically signiﬁcant. (*: Po0.003 when compared with no ﬂow group, D: Po0.003 when compared
with Y-27632 treated group, n: P o0.003 when compared with ﬂow group).
Fig. 6. Flow and rhoA regulate type I collagen (col1) protein deposition in AV cushion explants. Differential col1 protein expression level and deposition were observed
among different groups by confocal analysis. Cells from the cushion explants migrated into the collagen scaffold in the no ﬂow control and Y-27632-treated groups
(arrows, A, B, E). This was not observed in the other cultures. Green stain: col1; blue stain: Dapi; scale bar: 100 mm. In the case of ﬂow, direction is perpendicular to the
page. The dotted line denotes the scaffold/cushion interface.
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Fig. 7. Flow and rhoA regulate tenascin C protein deposition in AV cushion explants. Cultured AV cushions were cross-sectioned and then stained with tenascin C antibody.
Differential tenascin protein expression levels and deposition were observed among different groups by confocal analysis. Cells from the cushion explants that migrated
into the collagen scaffold can be seen in the no ﬂow control and Y-27632 no ﬂow groups (arrows, A, E). Green stain: tenascin C; blue stain: Dapi; scale bar: 100 mm. In the
case of ﬂow, direction is perpendicular to the page. The dotted line denotes the scaffold/cushion interface.
Fig. 8. Flow and rhoA regulate periostin protein deposition in AV cushion explants. Cultured AV cushions displayed differential periostin protein expression patterns
among the treatment groups. The rhoA/rho kinase pathway transduced the effects of ﬂow forces on AV cushions expressing periostin. Green stain: periostin; blue stain:
Dapi; scale bar: 100 mm. In the case of ﬂow, direction is perpendicular to the page. The dotted line denotes the scaffold/cushion interface.
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explants were similar to the AV cushions cultured inside sponta-
neously contracting ’cardiotube’ cultures (Goodwin et al., 2005;
Norris et al., 2009). Thus, the 7 day two-step ﬂow protocol used
here appears to be sufﬁcient to maintain ﬁbrous ECM expression
and leaﬂet morphogenesis of AV mesenchyme in an in vivo like
manner. However, as mentioned above a wide range of time
points and ﬂow conditions need to be tested to determine the
speciﬁc effects on valvulogenesis.The rhoA pathway is an important regulator of the actino-
myosin cytoskeleton and has been implicated as a mediator of
mechanical forces previously (reviewed Ingber). This, combined
with the extensive F-actin staining in the ﬂow cultured cells
indicates rhoA may be involved in the transduction of ﬂow-
generated forces in developing valve tissue. In our studies, the
7 day two-step ﬂow protocol upregulated rhoA at the message
level and increased the amount of active rhoA in comparison to
no-ﬂow controls. This indicates that exposure to increasing
Fig. 9. Flow and rhoA regulate AV explant stiffness. (A) The force–distance curves obtained from AFM showed an upward shift in ﬂow samples compared to the curve for
no ﬂow samples. Thus, ﬂow samples are stiffer than no-ﬂow controls. Samples treated with ﬂow and LPA exhibit an upward shift from the ﬂow alone curve and samples
treated with ﬂow and Y-27632 exhibit a downward shift from the no ﬂow curve (*: Po0.05). (B) AFM experiments demonstrated that samples without ﬂow had a modulus
lower than those exposed to ﬂow, samples exposed to ﬂow and Y-27632 had the lowest modulus, and LPA treatment doubled the modulus of tissues exposed to ﬂow.
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cytoskeleton of endocardial endothelial cells. Our AFM data
shows that cells on the surface of ﬂow cultured explants are
stiffer than cells on no ﬂow controls. This cellular stiffness is
increased when cultured with GTPase stimulating, LPA and
decreased when cultured with the ROCK inhibitor, Y-27632. This
indicates that ﬂow stimulates the rhoA/ROCK pathway, which
increases cytoskeletal tension in developing valve cells.
Our studies also found that deposition of ﬁbrous ECM proteins
in AV mesenchyme was regulated by ﬂow and altered by LPA and
Y-27632 treatments. This indicates that a rhoA/ROCK mechanism
is involved in regulating the expression and deposition of ﬁbrous
ECM proteins in AV mesenchymal cells. We posit that increasing
cytoskeletal tension stimulates AV mesenchyme to express
ﬁbrous ECM proteins including col1 and tenascin C. Whether this
process involves cell–cell/cell–ECM communication of ﬂow sig-
nals from valve endothelium to underlying mesenchyme or direct
mechanical stimulation of the entire valve anlagen requires
further experimentation.
The regulation of periostin expression in developing AV
mesenchyme appears different than col1 and tenascin C. Though
periostin expression was more wide-spread in ﬂow vs. no-ﬂow
cultures, Y-27632 treatment did not appear to down regulateperiostin expression and deposition as it did in col1 and tenascin
C (compare Figs. 6–8). This indicates that periostin is not induced
via a ROCK kinase dependent pathway. Since LPA does appear to
increase periostin deposition, perhaps another GTPase pathway
such as Rac or CDC42 is responsible for periostin induction.
RhoA has been shown to be involved in the early stages of
cushion development (Mercado-Pimentel et al., 2007; Park et al.,
2006; Townsend et al., 2008) and in the progression of adult valve
disease (Gu and Masters, 2011; Jiang et al., 2009). The data
presented here on the role of rhoA in the ﬁbrous maturation of
AV cushions connects these previous ﬁndings.
The ﬁndings reported here shed light on processes that shape
normal valve development, as valve maturation involves the
expression and localization of ﬁbrous ECM proteins required for
normal valve mechanics (Tan et al., 2011). Our results are also
relevant to studies dealing with cardiac birth defects. Previous
studies have shown that increased mechanical loading results in
abnormal development of the arterial pole (Lucitti et al., 2005;
Lucitti et al., 2006). In other studies, the developing outﬂow tract
was shown to exhibit signiﬁcant increases in the production of
col1 and col3 as well as increased arterial stiffness in load-
exposed vitelline artery ligation vessels during chick embryogen-
esis (Lucitti et al., 2006). Studies of human Tetralogy of Fallot
H. Tan et al. / Developmental Biology 374 (2013) 345–356 355(TOF) patients and surgically induced animal models of TOF have
also shown increased ﬁbrosis of the pulmonary outlet (Bedard
et al., 2009; Mills and Moolenaar, 2003; Ridley and Hall, 1992).
If rhoA is mediating these events as well, then it may be
therapeutically useful to target this pathway to prevent patholo-
gical valve remodeling.
Lastly, it has been proposed that to develop a clinically viable
tissue engineered heart valve, one of the key bioengineering
challenges is to determine how mechanical factors affect extra-
cellular matrix formation and in vivo functionality (Sacks et al.,
2009b). Therefore, this study has implications in tissue engineered
heart valve design as well. Overall, this study contributes to a
greater understanding of developmental mechanotransduction in
post-EMT AV cushions, and, for the ﬁrst time, proposes the rhoA
pathway as a necessary mediator of ﬁbrous valve development.
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